Our Press Releases

Review over Amyotrophic Lateral Sclerosis (ALS) and the First FDA-Approved Drug for Treatment of

  Molnupiravir may be effective against the omicron sub-variant BA.5 According to a study

The current monkeypox situation is consistently evolving and subject to change. The aim of

World AUTO immune & AUTO inflammatory Arthritis Day    This event historically unites thousands

  The ninth update of WHO’s guideline on COVID-19 therapeutics includes a conditional recommendation

Amyotrophic Lateral Sclerosis (ALS) Global Day Annually the International ALS/MND Associations celebrates 21 June

Breaking news; U.S FDA advisory panel narrowly endorses Molnupiravir   U.S FDA advisory panel